Alembic Pharma receives US FDA tentative approval for Ivabradine tablets
The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Corlanor tablets, 5 mg and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alembic Pharma
Aleor Dermaceuticals receives US FDA final approval for Lidocaine and Prilocaine cream
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product EMLA Cream, 2.5%/2.5%, of Teva Branded…
Alembic Pharma announces US FDA tentative approval for Dabigatran Etexilate capsules
The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Pradaxa capsules, 75 mg,…
Alembic Pharma acquires 100 per cent stake in Aleor Dermaceuticals
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
Alembic Pharma receives US FDA final approval for Lacosamide tablets
Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
Aleor Dermaceuticals receives US FDA final approval for Nystatin and Triamcinolone Acetonide…
The approved ANDA is therapeutically equivalent to the Reference Listed Drug product (RLD) Nystatin and Triamcinolone Acetonide…
Alembic Pharmaceuticals receives US FDA tentative approval for Vortioxetine tablets
The tablets are indicated for the treatment of Major Depressive Disorder (MDD)
Alembic Pharmaceuticals receives USFDA final approval for Entacapone tablets
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Comtan tablets, 200 mg, of Orion…
Alembic Pharmaceuticals receives US FDA approval for Doxycycline Hyclate delayed-release tablets
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Doryx tablets, 75 mg, 100 mg, 150 mg…
Alembic announces seed round investment in RIGImmune, Inc
Alembic has acquired preferred stock in RIGImmune amounting to a 19.97 per cent post-money stake in the first closing of the…